Gaurav Shah, CEO at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 6,276 shares at $2.98 ($19K) on 2025-11-18, disclosed to the SEC on 2025-11-20.
Open-market sale of $19k RCKT by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCKT | SELL | 2026-05-26 | $172K | — | Filing → |
| RCKT | SELL | 2026-05-21 | $7K | — | Filing → |
| RCKT | SELL | 2026-05-14 | $10K | — | Filing → |